August 24, 2018 · Advisors

After managing separate hedge funds for almost 20 years, Jacob and Stuart Weisbrod are now sharing office space. These two prominent geniuses of healthcare investing understand one another well since they once worked together at Merlin BioMed Group. Currently, they are operating under one roof with the expectation of working together in the future.

Stuart Weisbrod started his profession in 1998 when he co-founded the Merlin as an investment management firm that specialized in the healthcare sector. The portfolios of the company included the healthcare service sector, pharmaceutical, medical device, and biotechnology. Stuart has created an unbeaten track record in healthcare and biotechnology investment having held prestigious posts in leading companies such as Prudential-Bache securities, Merill Lynch, Harpel Partners and Oracle Partners. He has a remarkable academic career having earned a Ph.D. in Biochemistry from the University of Princeton in 1980. He also has an MBA in Finance from the University of Columbia in 1986.

Stuart Weisbrod’s extensive background equipped him with the necessary skills and network that helped him create a winning team. The team comprised Jacob Gottlieb, a genius in the healthcare investing who served as a portfolio manager for Merlin Company in 2000. When working at Merlin during the height of the biotech revolution, Jacob Gottlieb assisted the company attains higher returns of more than 100% in 1999 and 2000. Together with other two portfolio managers, Jacob managed to generate high income, and this assisted them to get prominent customers. Even though the company recorded tremendous success over the years, Merlin closed down in 2007 after refunding the funds to investors.

After Merlin was closed down, Weisbrod went on to establish a new investment company known as Iguana Healthcare Partners. These company shares the same investment strategy as that of Merlin since it concentrates on public firms in the healthcare sector.

Just like Weisbrod, Gottlieb moved to establish his company after he left Merlin. After numerous years of hard work and success in the financial industry, Gottlieb invested $300 million in building the Asset Management Company known as Visium. After his company survived the 2008 economic recession, Gottlieb expanded his company into an $8 billion hedge fund. He opened up various offices in London, New York, and San Francisco.

Irrespective of numerous years of success, Visium’s business operations came at a halt in 2016. However, Gottlieb has continued to serve the company to refund the cash to investors and close down the business. With Weisbrod and Gottlieb, former workmates and vastly successful financial capitalists working under one roof, the industry is sure to experience miraculous transformations for healthcare investments opportunities.

Written by


Leave a Reply

You must be logged in to post a comment.